Publications by authors named "V M Riccardi"

Encephalitis affects 1.9 to 14.3 people per 100,000 each year, and the mortality rate varies but can be up to 40%.

View Article and Find Full Text PDF

Durum wheat (DW) is one of the major crops grown in the Mediterranean area, a climate-vulnerable region where the increase in day/night (d/n) temperature is severely threatening DW yield stability. In order to improve DW heat tolerance, the introgression of chromosomal segments derived from the wild gene pool is a promising strategy. Here, four DW- spp.

View Article and Find Full Text PDF

Aging is characterized by increased oxidation and reduced efficiency of cytoprotective mechanisms. Nuclear factor erythroid-2-related factor (Nrf2) is a key transcription factor, controlling the expression of multiple antioxidant proteins. Here, we show that Nrf2 mice displayed an age-dependent anemia, due to the combined contributions of reduced red cell lifespan and ineffective erythropoiesis, suggesting a role of Nrf2 in erythroid biology during aging.

View Article and Find Full Text PDF

Inflammatory vasculopathy is critical in sickle cell disease (SCD)-associated organ damage. An imbalance between pro-inflammatory and pro-resolving mechanisms in response to different triggers such as hypoxia/reoxygenation or infections has been proposed to contribute to the progression of SCD. Administration of specialized pro-resolving lipid mediators may provide an effective therapeutic strategy to target inflammatory vasculopathy and to modulate inflammatory response.

View Article and Find Full Text PDF
Article Synopsis
  • Drug repurposing is an effective approach for addressing unmet needs in rare diseases like sickle cell disease (SCD), which causes painful episodes and chronic complications.
  • New therapeutic options have emerged from understanding SCD's pathophysiology, but many patients still experience frequent vaso-occlusive crises (VOCs) and disease progression.
  • Imatinib, originally developed for chronic myelogenous leukemia, shows promise as a multimodal treatment for SCD by targeting pathways related to anemia and inflammation.
View Article and Find Full Text PDF